BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38280659)

  • 1. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
    Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
    Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein.
    Srivastava A; Alam P; Caughey B
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
    Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
    Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
    Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis.
    Yoo D; Bang JI; Ahn C; Nyaga VN; Kim YE; Kang MJ; Ahn TB
    Parkinsonism Relat Disord; 2022 Nov; 104():99-109. PubMed ID: 36289019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
    Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
    Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease.
    Bongianni M; Catalan M; Perra D; Fontana E; Janes F; Bertolotti C; Sacchetto L; Capaldi S; Tagliapietra M; Polverino P; Tommasini V; Bellavita G; Kachoie EA; Baruca R; Bernardini A; Valente M; Fiorini M; Bronzato E; Tamburin S; Bertolasi L; Brozzetti L; Cecchini MP; Gigli G; Monaco S; Manganotti P; Zanusso G
    Transl Neurodegener; 2022 Jul; 11(1):37. PubMed ID: 35902902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein Seeding Assay Using RT-QuIC.
    Okuzumi A; Hatano T; Fukuhara T; Ueno S; Nukina N; Imai Y; Hattori N
    Methods Mol Biol; 2021; 2322():3-16. PubMed ID: 34043187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
    Kurapova R; Chouliaras L; O'Brien JT
    Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
    Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid.
    Concha-Marambio L; Pritzkow S; Shahnawaz M; Farris CM; Soto C
    Nat Protoc; 2023 Apr; 18(4):1179-1196. PubMed ID: 36653527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
    Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
    Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis.
    Grossauer A; Hemicker G; Krismer F; Peball M; Djamshidian A; Poewe W; Seppi K; Heim B
    Mov Disord Clin Pract; 2023 May; 10(5):737-747. PubMed ID: 37205253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain and Cerebrospinal Fluid α-Synuclein Real-Time Quaking-Induced Conversion Identifies Lewy Body Pathology in LRRK2-PD.
    Garrido A; Fairfoul G; Tolosa E; Marti MJ; Ezquerra M; Green AJE
    Mov Disord; 2023 Feb; 38(2):333-338. PubMed ID: 36471633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of Method for the Determination of Aggregated α-Synuclein in DLB Patient Using RT-QuIC Assay.
    Park SJ; Lee YJ; Park JH; Jin HT; Choi MJ; Jung CG; Akatsu H; Choi EK; Kim YS
    Protein Pept Lett; 2021; 28(1):115-120. PubMed ID: 32310037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.
    Bellomo G; Paciotti S; Concha-Marambio L; Rizzo D; Wojdaƚa AL; Chiasserini D; Gatticchi L; Cerofolini L; Giuntini S; De Luca CMG; Ma Y; Farris CM; Pieraccini G; Bologna S; Filidei M; Ravera E; Lelli M; Moda F; Fragai M; Parnetti L; Luchinat C
    Mol Neurodegener; 2023 Apr; 18(1):20. PubMed ID: 37005644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seed amplification assays for diagnosing synucleinopathies: the issue of influencing factors.
    Bellomo G; Paciotti S; Gatticchi L; Rizzo D; Paoletti FP; Fragai M; Parnetti L
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1075-1088. PubMed ID: 34856754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.